View in EDS PDF Full Text

FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate.

Saved in:
Bibliographic Details
Title: FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate.
Authors: Yang J; Institute of Life Sciences, China Medical University, Shenyang, China., Chen L; Institute of Life Sciences, China Medical University, Shenyang, China., Zhao SS; Institute of Life Sciences, China Medical University, Shenyang, China., Du C; Institute of Life Sciences, China Medical University, Shenyang, China., Fan YZ; Institute of Life Sciences, China Medical University, Shenyang, China., Liu HX; Institute of Life Sciences, China Medical University, Shenyang, China., Li Y; The Sixth Affiliated Hospital of South China University of Technology, Foshan, Guangdong, China., Li YZ; Department of Urology, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.; Liaoning Key Laboratory of Bladder Disease Gene Research, Institute of Health Science, China Medical University, Shenyang, China.
Source: Frontiers in pharmacology [Front Pharmacol] 2024 Jul 08; Vol. 15, pp. 1422770. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39040469
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Institute of Life Sciences, China Medical University, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Institute of Life Sciences, China Medical University, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Zhao+SS%22">Zhao SS</searchLink>; Institute of Life Sciences, China Medical University, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Du+C%22">Du C</searchLink>; Institute of Life Sciences, China Medical University, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Fan+YZ%22">Fan YZ</searchLink>; Institute of Life Sciences, China Medical University, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Liu+HX%22">Liu HX</searchLink>; Institute of Life Sciences, China Medical University, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; The Sixth Affiliated Hospital of South China University of Technology, Foshan, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Li+YZ%22">Li YZ</searchLink>; Department of Urology, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.; Liaoning Key Laboratory of Bladder Disease Gene Research, Institute of Health Science, China Medical University, Shenyang, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2024 Jul 08; Vol. 15, pp. 1422770. <i>Date of Electronic Publication: </i>2024 Jul 08 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39040469
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2024.1422770
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1422770
    Titles:
      – TitleFull: FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yang J
      – PersonEntity:
          Name:
            NameFull: Chen L
      – PersonEntity:
          Name:
            NameFull: Zhao SS
      – PersonEntity:
          Name:
            NameFull: Du C
      – PersonEntity:
          Name:
            NameFull: Fan YZ
      – PersonEntity:
          Name:
            NameFull: Liu HX
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Li YZ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 07
              Text: 2024 Jul 08
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1